No need for ivermectin clinical trial in PH — DOST

Aileen Cerrudo   •   April 10, 2021   •   1835

MANILA, Philippines—There is no need to conduct clinical trials in the Philippines for ivermectin, according to the Department of Science and Technology (DOST).

The DOST’s  Philippine Council for Health Research and Development (PCHRD) said there are already clinical trials being conducted around the world to determine the effectivity of ivermectin in treating the coronavirus disease (COVID-19).

“There are almost 20 completed and 40 ongoing clinical trials around the world as reported in clinicaltrials.gov exploring the use of Ivermectin formulations against COVID-19,” the department said in a statement.

The DOST explained that clinical trial projects will require a minimum of 6 months and can extend to years.

“It would be appropriate to await the results of these studies that are already significantly advanced in terms of data collection and conducting interim analyses,” the department further said. AAC

 

 

Phivolcs records sequence of earthquakes in Bicol region

Maris Federez   •   October 18, 2021

MANILA, Philippines — The Department of Science and Technology-Philippine Institute of Volcanology and Seismology (DOST-Phivolcs) has recorded a sequence of small earthquakes in the Bicol region following a small shallow-seated earthquake with a magnitude of 4.3 and depth of 4 kilometers occurred at 10:08 p.m. on October 14.

The location of the epicenter of the 4.3 magnitude quake was determined to be at 13.65 north latitude and 123.14 east longitude or at 3 kilometers North and 75 kilometers west of Canaman, Camarines Sur.

A total of 27 earthquakes were recorded by the nearest DOST-Phivolcs earthquake monitoring station located in San Jose, Camarines Sur (Station Code: SCSP).

Magnitude ranges from 1.7 to 4.3 with crustal shallow depths between 1 to 40 kilometers.

The last recorded event associated with this earthquake sequence was at 1:22 a.m. on Monday, October 18.

There was no similar event that followed as of 6:00 a.m.

Phivolcs also recorded ten events that were felt at various intensities in the provinces of Camarines Norte, Camarines Sur and Albay.

Calculation of the intensity distribution for the first event was performed using the Rapid Earthquake Damage Assessment System (Redas) software using the latest calculated parameters of the earthquake, according to the statement released by the DOST.

Results show that the magnitude and shallow depth of this inland event has the potential to cause damage in the general vicinity of the epicenter.

The department said it immediately informed the Office of Civil Defense (OCD) about this during the information release of the first event.

The DOST also noted that social media posts indicate that the event was widely felt with unconfirmed observations of non-structural damage (glass door was damaged) and damage to building content.

This prompted OCD to instruct their regional office to investigate the reported damage in the affected areas.

DOST-Phivolcs said that based on the collected data, this sequence of events, showing no identifiable large event, can be considered as an earthquake swarm that may occur in a tectonically active region, as suggested by sparse seismicity in this area of the Bicol region.

DOST-Phivolcs said it will closely monitor any progress of this earthquake activity and will continue to post updated information at the Phivolcs Official website.

Ivermectin clinical trials to push through this September despite delays — DOST

Marje Pelayo   •   September 6, 2021

MANILA, Philippines — The Department of Science and Technology (DOST) said preparations are almost done for the start of the ivermectin clinical trial this month.

The clinical trial is necessary to find out if the controversial drug is effective against COVID-19, Dr. Jaime Montoya of the DOST-Philippine Council for Health Research and Development (PCHRD) said.

During the Laging Handa public briefing, Montoya said the agency had to adjust its protocol based on the standards of the international consortium before it launches the clinical trial for ivermectin.

“Dahil po may mga nag-review ng ating mga protocol na galing sa international reviewers po ay binago po natin ang ilang aspeto sa ating protocol para mapaganda pa po ito,” Montoya said.

Montoya added that the clinical trial for ivermectin in the country is supported by major international health bodies like the World Health Organization (WHO), the National Institute on Health, and the Centers for Disease Control (CDC).

Also, he noted the importance of the clinical trial to come up with evidence on its effectiveness against COVID-19, with Filipinos as the concentration of the trial.

“Napakahalaga na magkaroon tayo ng lokal na datos tungkol sa mga Pilipino na nabibigyan ng gamot na ito, tungkol sa safety issue, sa mga side effects, kung ito po ay totoong mabisa sa mga Pilipinong may COVID-19,” he said.

“Kailangan gumawa pa ng clinical trial para magkaroon ng sapat na ebidensya kung ito ba ay magagamit o hindi para sa COVID-19,” he added.

Currently, the DOST’s requirements are being evaluated by the consortium’s ethics committee.

Once it is finished, the DOST hopes the clinical trial for ivermectin will push through this month as initially planned.

“Ito po sa kasalukuyan ay tinatapos na ang ethics at technical review bago po ito magsimula dahil ang target natin ay this month po ‘yan dapat magsimula,” he said.

DOH, muling iginiit na hindi gamot ang ivermectin vs COVID-19

Robie de Guzman   •   August 23, 2021

MANILA, Philippines — Inulit ng Department of Health (DOH) ang babala nito hinggil sa basta-bastang pag-inom ng ivermectin bilang gamot sa COVID-19.

Ginawa ng DOH ang pahayag matapos sabihin ng United States Food and Drug Administration (USFDA) na hindi dapat gamitin kontra COVID-19 ang ivermectin na isang animal grade o ginawa para gamutin ang parasitic infection sa mga hayop.

“Ito pong gamot na ito nagpakita na po ng ebidensya na ito pong gamot na ito doesn’t give you any benefit at all in preventing, in shortening the duration of your hospitalization or preventing the progression of your disease when you have COVID-19” ani DOH Undersecretary Maria Rosario Vergeire.

“Itong gamot na ito ay may side effects in na harmful sa inyong katawan,” dagdag pa niya.

Ang babala ng USFDA ay kasunod ng mga pagdami ng mga kaso ng umano’y naoospital sa Amerika dahil sa paggamit ng ivermectin kontra COVID-19.

Sa estado ng Mississippi, iniulat ng Poison Control Center na 70% ng tawag na kanilang natatanggap ay dahil sa pag-inom ng animal grade na ivermectin na binili sa livestock centers.

Ayon sa ahensya, hindi dapat inumin ng mga tao ang animal drugs dahil ito ay concentrated para sa mga malalaking hayop at toxic para sa tao.

Una na ring nagbabala ang World Health Organization laban sa paggamit ng ivermectin bilang gamot sa COVID-19, maliban na lamang kung ito ay para sa isang clinical trial. RRD (mula sa ulat ni Correspondent Aiko Miguel)

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.